426219-41-2 Usage
Description
1-(1-trityl-1H-imidazol-4-yl)propane-1,3-diol is a chemical compound with the molecular formula C26H25N2O2. It is a derivative of imidazole and propane-1,3-diol, and it contains a trityl group, which is a phenylmethyl protecting group. 1-(1-trityl-1H-imidazol-4-yl)propane-1,3-diol is a valuable intermediate in the production of a wide range of chemical compounds and is widely used in research and industrial applications.
Uses
Used in Organic Chemistry:
1-(1-trityl-1H-imidazol-4-yl)propane-1,3-diol is used as a reagent for the synthesis of other organic compounds. Its unique structure and functional groups make it a versatile building block in organic synthesis.
Used in Pharmaceutical Industry:
1-(1-trityl-1H-imidazol-4-yl)propane-1,3-diol is used as a building block for the preparation of various pharmaceuticals and biologically active molecules. Its ability to form stable derivatives and protect functional groups during synthesis makes it a valuable component in the development of new drugs.
Used in Research Applications:
1-(1-trityl-1H-imidazol-4-yl)propane-1,3-diol is used as a research tool to study the properties and reactivity of imidazole and propane-1,3-diol derivatives. Its unique structure allows researchers to explore new synthetic pathways and develop innovative applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 426219-41-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,2,6,2,1 and 9 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 426219-41:
(8*4)+(7*2)+(6*6)+(5*2)+(4*1)+(3*9)+(2*4)+(1*1)=132
132 % 10 = 2
So 426219-41-2 is a valid CAS Registry Number.
426219-41-2Relevant articles and documents
Novel imidazole derivatives, production method thereof and use thereof
-
, (2008/06/13)
The present invention provides a compound having a steroid C17,20-lyase-inhibitory activity and useful for the therapy and prophylaxis of tumor such as prostatism, breast cancer and the like, and a method for efficiently separating an optically active compound of this compound from a mixture of optical isomers thereof, a compound of the formula: wherein each symbol is as defined in the specification, a salt thereof or a prodrug thereof, and a method for obtaining an optically active compound by optically resolving a mixture of optical isomers by the use of a resolving agent such as tartranilic acid and the like.
